News Room

One way or another, millions more South Carolinians need to acquire immunity from the coronavirus before the disease is at bay. The goal is herd immunity, and it is a moving target. Jane Kelly, assistant state epidemiologist with the South Carolina Department of Health and Environmental Control, said last week that community spread of the disease should stop once 70 percent of the population has acquired immunity. That’s herd immunity. But, she said, public health experts must set the bar higher — up to 85 percent — in places where infections are rampant.

“It’s a marathon not a sprint,” said Alamance County Health Director Tony Lo Giudice talking about the COVID-19 vaccine rollout. Lo Giudice was candid about the obstacles the Health Department faces in getting close to 170,000 Alamance County residents inoculated against the coronavirus – inoculating the public from unrealistic expectations. Right now the biggest one is the meager 975 doses per week the state is allocating to Alamance County. “There is still a trickle of vaccine,” said Julie Swann, head of the Industrial Systems Engineering Department at N.C. State and an expert in how health systems operate, “and high expectations.”

The sluggish rollout of COVID-19 vaccines across the United States highlights the challenges of a decentralized distribution plan that relies on states and localities to handle the complicated last-mile logistics of getting shots into people's arms, reported The Wall Street Journal on Monday. More than 22 million doses had been distributed to states and other jurisdictions as of Friday, according to the Centers for Disease Control and Prevention (CDC), while 6.7 million people had received their first shot by that point. The figures were short of the U.S. goal of 20 million vaccinations by the end of 2020, and communities and states were still reporting bottlenecks this month as they managed their inoculation programs, said the Journal.

The output from Operation Warp Speed is struggling to get its footing. The billions of dollars invested focused primarily on developing a safe and effective vaccine as quickly as possible. Equally needed was how to effectively traverse all the links in the supply chain, particularly the last mile, to transform those vaccines into vaccinations. As a result, millions of doses of vaccines sit on shelves while willing recipients anxiously await their turn to be immunized. What went wrong and what can be done today to make this right?  

For many of us, one of the upsides of 2020 was being freed from the grind of the daily commute. For the 40% of the workforce able to “telecommute”, COVID-19 social distancing measures saved us an average of about an hour a day – and much more for those of us living in the outer suburbs of cities. Studies show the morning commute is the least favourite part of the day, and the commute home the third-least favourite (working is the second-least favourite). Congestion, crowding and unpredictability increase stress and dissatisfaction. The longer it takes, and the more we have to do in the company of others, the more we dislike it.